This enables the measuring accuracy of the blood pressure watch to be increased by more than 70 per cent. Clinical trials of the device are currently under way. The first measurements have already been taken in parallel with a catheter procedure - with very promising results.
After menopause, a woman's risk of high blood pressure and other cardiovascular diseases increases greatly; the risk increases significantly faster for women after hysterectomy, perhaps because the uterus produces chemicals that help regulate blood pressure.
There is an increased risk of blood clots including a potentially deadly pulmonary embolus, a blood clot in the lungs. Uterine and breast cancers have also been linked to HRT. And the WHI study has shown an increased risk of heart disease in women 10 years or more past menopause who take HRT.